Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations

DOJ press release (4 Nov 2013), J&J more than $2.2 billion: Janssen plea $400 million (fine $334 million, forfeiture $66 million); Risperdal/Invega civil $1.273 billion (federal $749 million, states $524 million; $1.391 billion with $118 million paid to Texas in 2012); Omnicare kickbacks $149 million (federal $132 million, states $17 million; Omnicare paid $98 million in 2009); Natrecor $184 million (Scios 2011 fine $85 million); whistleblowers E.D. Pa. $112 million, D. Mass. $27.7 million, N.D. Cal. $28 million; CIA; FCA recoveries since January 2009 (more than $16.7 billion; more than $11.9 billion health care); FDCA more than $6 billion since 2009 (not FCA, not recorded). Already in the data: 1 case (its award is a sum computed by an earlier pass). Added: 3 cases (one per civil settlement, matched to the whistleblower payment by district) and 2 cumulative FCA recovery observations.